Molecular Biomarkers in Thyroid FNA SamplesMARINA MELILLO, Rosa; SANTORO, Massimo.The Journal of clinical endocrinology and metabolism. 2012, Vol 97, Num 12, pp 4370-4373, issn 0021-972X, 4 p.Article

Is Co-option a Prevailing Mechanism during Cancer Progression?BILLAUD, Marc; SANTORO, Massimo.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 21, pp 6572-6575, issn 0008-5472, 4 p.Article

Targeting the RET Pathway in Thyroid CancerWELLS, Samuel A; SANTORO, Massimo.Clinical cancer research (Print). 2009, Vol 15, Num 23, pp 7119-7123, issn 1078-0432, 5 p.Article

Receptor tyrosine kinases as targets for anticancer therapeuticsCARLOMAGNO, Francesca; SANTORO, Massimo.Current medicinal chemistry. 2005, Vol 12, Num 15, pp 1773-1781, issn 0929-8673, 9 p.Article

RET/PTC activation in papillary thyroid carcinoma : European journal of endocrinology prize lectureSANTORO, Massimo; MELILLO, Rosa Marina; FUSCO, Alfredo et al.European journal of endocrinology. 2006, Vol 155, Num 5, pp 645-653, issn 0804-4643, 9 p.Article

The RET receptor: function in development and dysfunction in congenital malformationMANIE, Serge; SANTORO, Massimo; FUSCO, Alfredo et al.Trends in genetics (Regular ed.). 2001, Vol 17, Num 10, pp 580-589, issn 0168-9525Article

Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An UpdateWELLS, Samuel A; PACINI, Furio; ROBINSON, Bruce G et al.The Journal of clinical endocrinology and metabolism. 2013, Vol 98, Num 8, pp 3149-3164, issn 0021-972X, 16 p.Article

Prevalence and clinical correlates of sleep disordered breathing in myotonic dystrophy types 1 and 2BIANCHI, Maria Laura Ester; LOSURDO, Anna; DI BLASI, Chiara et al.Sleep & breathing. 2014, Vol 18, Num 3, pp 579-589, issn 1520-9512, 11 p.Article

RET Is a Heat Shock Protein 90 (HSP90) Client Protein and Is Knocked Down upon HSP90 Pharmacological BlockALFANO, Luigi; GUIDA, Teresa; PROVITERA, Livia et al.The Journal of clinical endocrinology and metabolism. 2010, Vol 95, Num 7, pp 3552-3557, issn 0021-972X, 6 p.Article

Biological Role and Potential Therapeutic Targeting of the Chemokine Receptor CXCR4 in Undifferentiated Thyroid CancerDE FALCO, Valentina; GUARINO, Valentina; AVILLA, Elvira et al.Cancer research (Baltimore). 2007, Vol 67, Num 24, pp 11821-11829, issn 0008-5472, 9 p.Article

The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteinsIERVOLINO, Angela; IULIANO, Rodolfo; TRAPASSO, Francesco et al.Cancer research (Baltimore). 2006, Vol 66, Num 12, pp 6280-6287, issn 0008-5472, 8 p.Article

BRAF mutations are not a major event in post-chernobyl childhood thyroid carcinomasLIMA, Jorge; TROVISCO, Vitor; JEREMIAH, Steve et al.The Journal of clinical endocrinology and metabolism. 2004, Vol 89, Num 9, pp 4267-4271, issn 0021-972X, 5 p.Article

Establishment of a non-tumorigenic papillary thyroid cell line (FB-2) carrying the RET/PTC1 rearrangementBASOLO, Fulvio; GIANNINI, Riccardo; FIORE, Lisa et al.International journal of cancer. 2002, Vol 97, Num 5, pp 608-614, issn 0020-7136Article

Inhibitory effects of peroxisome proliferator-activated receptor γ on thyroid carcinoma cell growthMARTELLI, Maria Luisa; IULIANO, Rodolfo; LE PERA, Ilaria et al.The Journal of clinical endocrinology and metabolism. 2002, Vol 87, Num 10, pp 4728-4735, issn 0021-972XArticle

Thyroid cell transformation requires the expression of the HMGA1 proteinsBERLINGIERI, Maria Teresa; PIERANTONI, Giovanna M; GIANCOTTI, Vincenzo et al.Oncogene (Basingstoke). 2002, Vol 21, Num 19, pp 2971-2980, issn 0950-9232Article

High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growthPIERANTONI, Giovanna Maria; FEDELE, Monica; PENTIMALLI, Francesca et al.Oncogene (Basingstoke). 2001, Vol 20, Num 43, pp 6132-6141, issn 0950-9232Article

Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2)SANTORO, Massimo; MODONI, Anna; MASCIULLO, Marcella et al.Experimental and molecular pathology. 2010, Vol 89, Num 2, pp 158-168, issn 0014-4800, 11 p.Article

Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma CellsSALERNO, Paolo; DE FALCO, Valentina; TAMBURRINO, Anna et al.The Journal of clinical endocrinology and metabolism. 2010, Vol 95, Num 1, pp 450-455, issn 0021-972X, 6 p.Article

The RET kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cellsAKENO-STUART, Nagako; CROYLE, Michelle; CARAVATTI, Giorgio et al.Cancer research (Baltimore). 2007, Vol 67, Num 14, pp 6956-6964, issn 0008-5472, 9 p.Article

In vivo and in vitro characterization of a novel germline RET mutation associated with low-penetrant nonaggressive familial medullary thyroid carcinomaD'ALOISO, Leonardo; CARLOMAGNO, Francesca; FILETTI, Sebastiano et al.The Journal of clinical endocrinology and metabolism. 2006, Vol 91, Num 3, pp 754-759, issn 0021-972X, 6 p.Article

Mutation of the PIK3CA gene in anaplastic thyroid cancerGARCIA-ROSTAN, Ginesa; COSTA, Angela M; PEREIRA-CASTRO, Isabel et al.Cancer research (Baltimore). 2005, Vol 65, Num 22, pp 10199-10207, issn 0008-5472, 9 p.Article

Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cellsVITAGLIANO, Donata; CARLOMAGNO, Francesca; SANTORO, Massimo et al.Cancer research (Baltimore). 2004, Vol 64, Num 11, pp 3823-3829, issn 0008-5472, 7 p.Article

The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinomaMELILLO, Rosa Marina; CIRAFICI, Anna Maria; SANTORO, Massimo et al.The American journal of pathology. 2004, Vol 165, Num 2, pp 511-521, issn 0002-9440, 11 p.Article

Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosisSPALLETTI-CERNIA, Daniela; SORRENTINO, Rosanna; DI GAETANO, Sonia et al.The Journal of clinical endocrinology and metabolism. 2003, Vol 88, Num 6, pp 2900-2907, issn 0021-972X, 8 p.Article

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomasNIKIFOROVA, Marina N; KIMURA, Edna T; SANTORO, Massimo et al.The Journal of clinical endocrinology and metabolism. 2003, Vol 88, Num 11, pp 5399-5404, issn 0021-972X, 6 p.Article